Skip to main content
SpringerLink
Log in

Complications of hypertension and their relation to therapy

  • Chapter
Lifelong Management of Hypertension

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 26))

  • 46 Accesses

Abstract

In general people do not die of high blood pressure itself but of its complications. Today most of these complications are considered to be the result of arteriosclerosis and involve the heart or the head: myocardial infarction or thrombotic brain infarction. These so-called arteriosclerotic complications of mild and moderate hypertension have become relatively more frequent as the overall severity of hypertension has decreased during the last few decades. In the past, when severe hypertension was more common, complications, related more directly to elevated blood pressure, were also more common. These complications were renal failure, cerebral hemorrhage and congestive heart failure in the presence of an elevated pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dawber TR: The Framingham Study. Cambridge, Mass, Harvard University Press, 1980.

    Google Scholar 

  2. Stallones RA: The rise and fall of ischemic heart disease. Sci Am 243(5): 1980.

    Google Scholar 

  3. Smith DE, Odel HM, Kernohan JW: Causes of death in hypertension. Am J Med 9:516–527, 1950.

    Article  PubMed  CAS  Google Scholar 

  4. Perera GA: Hypertensive vascular disease: description and natural history. J Chronic Dis 1:33–42, 1955.

    Article  PubMed  CAS  Google Scholar 

  5. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. 1. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202:116–122, 1967.

    Article  Google Scholar 

  6. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213:1143–1152, 1970.

    Article  Google Scholar 

  7. Veterans Administration Cooperative Study Group in Antihypertensive Agents: Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 45:991–1004, 1972.

    Google Scholar 

  8. Reader R (Study-Director): A report by the Management Committee in the Australian Therapeutic Trial in Mild Hypertension untreated mild hypertension. Lancet 1:158, 1982.

    Google Scholar 

  9. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562, 1979.

    Article  Google Scholar 

  10. The Multiple Risk Factor Intervention Trial. JAMA 248:1465, 1982.

    Google Scholar 

  11. Perry HM Jr: Mild Hypertension-when and how to treat it. Praxis 71:265, 1982.

    PubMed  Google Scholar 

  12. Hypertension-Stroke Cooperative Study Group: Effect of antihypertensive treatment on stroke recurrence. JAMA 299:409–418, 1974.

    Google Scholar 

  13. Johnston JH et al: The importance of good blood pressure control in the prevention of stroke recurrence in hypertensive patients. Postgrad Med J 57:690–693, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. The Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and re-infarction in patients surviving acute myocardial infarction. N Engl J Med 304(14):801–807, 1981.

    Article  Google Scholar 

  15. B-Blocker Heart Attack Study Group: The B-blocker Heart Attack Trial. JAMA 246(18): 2073–2074, 1981.

    Article  Google Scholar 

  16. Multicenter International Study: Supplementary report: reduction in mortality after myocardial infarction long-term beta-adrenoceptor blockade. Br Med J [Clin Res] 2:419–421, 1977.

    Article  Google Scholar 

  17. The 1980 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 40:1280, 1980.

    Google Scholar 

  18. Perry HM Jr, O’Neal R, Thomas WA: Pulmonary disease following chronic chemical gan-glionic blockade: a clinical and pathological study. Am J Med 22:37, 1957.

    Article  PubMed  Google Scholar 

  19. Perry HM Jr, Schroeder HA: Syndrome simulating collagen disease caused by 1-hydrazin-ophthalazine (Apresoline). JAMA 154:670, 1954.

    Google Scholar 

  20. Perry HM Jr: Possible mechanisms of the hydralazine-related lupus-like syndrome, arthritis and rheumatism 24; 8:1093–1105.

    Google Scholar 

  21. Schroeder HA, Perry HM Jr: Psychosis apparently produced by reserpine. JAMA 159:839, 1955.

    CAS  Google Scholar 

  22. Freis ED: Mental depression in hypertensive patients treated for a long period with large doses of reserpine. N Engl J Med 251:1006, 1954.

    Article  PubMed  CAS  Google Scholar 

  23. Veterans Administration Medical Centers: Low doses vs standard dose of reserpine. 248:2471–2477, 1982.

    Google Scholar 

  24. Goldstein GB, Lam KC, Mistilis SP: Drug-induced active chronic hepatitis. Am J Dig Dis 18:177–184, 1973.

    Article  PubMed  CAS  Google Scholar 

  25. Geyskes GG, Boer P, Dorhout Mees EJ: Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol 7:55–62, 1979.

    PubMed  CAS  Google Scholar 

  26. Goldman AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, Perry HM Jr: JAMA 244:1691, 1980.

    Article  PubMed  CAS  Google Scholar 

  27. Holland AB, Nicon JA, Kuhnert L: Diuretic-induced ventricular ectopia activity. Am J Med 70:762, 1981.

    Article  PubMed  CAS  Google Scholar 

  28. Perry HM: VA-NHLBI Study Group for Cooperative Studies on Antihypertensive Therapy: Mild hypertension. Circ Res 40:1–180, 1977.

    Google Scholar 

  29. Leren P: The Oslo Diet-Heart Study. Circulation 42:935, 1970.

    PubMed  CAS  Google Scholar 

  30. The Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. JAMA 231:306, 1975.

    Google Scholar 

  31. Oliver MF, Heady JA, Morris NN, Cooper J: A cooperative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 40:1069, 1978.

    Article  Google Scholar 

  32. Murphy MD, Kohner E, Lewis PJ, Schuber B, Dollery CJ: Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up. Lancet 2:1293–1295, 1982.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Mitchell Perry Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William H. Neal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. U.S. Veterans Administration, Washington, DC, USA

    H. Mitchell Perry Jr. M.D. (Physician Coordinator for Hypertension) (Physician Coordinator for Hypertension)

  2. Hypertension Division Department of Medicine, Washington University School of Medicine, Saint Louis, MO, 63106, USA

    H. Mitchell Perry Jr. M.D. (Physician Coordinator for Hypertension) (Physician Coordinator for Hypertension)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Perry, H.M., Neal, W.H. (1983). Complications of hypertension and their relation to therapy. In: Perry, H.M. (eds) Lifelong Management of Hypertension. Developments in Cardiovascular Medicine, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6732-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6732-8_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6734-2

  • Online ISBN: 978-94-009-6732-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation